APHA Aphria Inc.
Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini in 2013 and is headquartered in Leamington, Canada.
Company profile
Ticker
APHA
Exchange
Website
CEO
Irwin David Simon
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
APHA stock data
()
Calendar
29 Jul 20
30 Nov 20
31 May 21
News
Financial summary
| Annual (USD) | May 20 | May 19 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
Financial data from Aphria earnings reports.
Institutional ownership Q3 2020
10.6% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 164 |
| Opened positions | 23 |
| Closed positions | 29 |
| Increased positions | 42 |
| Reduced positions | 34 |
13F shares |
Current |
|---|---|
| Total value | 158.93M |
| Total shares | 30.72M |
| Total puts | 5.52M |
| Total calls | 5.25M |
| Total put/call ratio | 1.1 |
Largest owners |
Shares | Value |
|---|---|---|
| Vanguard | 7.5M | $33.22M |
| Etf Managers | 4.95M | $21.92M |
| Susquehanna International | 2.3M | $10.17M |
| Peconic Partners | 2.02M | $8.93M |
| BMO Bank of Montreal | 1.03M | $5.04M |
| MS Morgan Stanley | 932.54K | $4.13M |
| TD Asset Management | 922.23K | $4.08M |
| Public Sector Pension Investment Board | 818.25K | $3.62M |
| AdvisorShares Investments | 735.69K | $3.26M |
| Swiss National Bank | 579.3K | $2.56M |
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
Current reports
6-K
Aphria Inc. Closes Accretive, Strategic Acquisition of Sweetwater Brewing Company
30 Nov 20
6-K
Current report (foreign)
27 Nov 20
6-K
Aphria Inc. Expands 510 Vape Offerings Across Its Award-Winning Adult-Use Brand Portfolio
27 Nov 20
6-K
Increases Shelf Prospectus by USD $50 Million to Accommodate Equity to be Issued as Part of Consideration for the Acquisition of SweetWater
20 Nov 20
6-K
Aphria Inc. Announces Results of its 2020 Annual General Meeting
18 Nov 20
6-K
Aphria Inc. to Present at the Jefferies Virtual London Healthcare Conference
13 Nov 20
6-K
Agreement of Merger and Acquisition
5 Nov 20
6-K
Material Change Report
4 Nov 20
6-K
ODI Pharma AB and Aphria Inc. Execute Supply Agreement
2 Nov 20
6-K
Notice of Annual Meeting of Shareholders
16 Oct 20
Registration and prospectus
SUPPL
Supplemental materials (foreign)
27 Nov 20
F-X
Appointment of agent for service of process by issuers registering securities
19 Nov 20
F-10
Registration of securities (Canada)
19 Nov 20
SUPPL
Supplemental materials (foreign)
29 Jul 20
8-A12B
Registration of securities on exchange
5 Jun 20
25
Voluntary exchange delisting
5 Jun 20
RW
Registration withdrawal request
27 Mar 20
F-3
Shelf registration (foreign)
3 Mar 20
SUPPL
Supplemental materials (foreign)
31 Jan 20
F-10/A
Registration of securities (Canada) (amended)
22 Nov 19
Proxies
No filings